March 07, 2022
3 min watch
Save
VIDEO: Gel stent shows good results at 1 year in noninferiority study
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
NASHVILLE, Tenn. — At the American Glaucoma Society meeting, Arsham Sheybani, MD, discusses results from the Gold Standard Pathway Study, which evaluated the effectiveness and safety of the Xen gel stent (Allergan) vs. trabeculectomy.
Published by:
Sources/Disclosures
Collapse
Source:
Arsham Sheybani, MD
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.